Title: Teratogen update: antithyroid drugs—methimazole, carbimazole, and propylthiouracil
Abstract: TeratologyVolume 65, Issue 1 p. 38-44 Teratogen UpdateFree Access Teratogen update: antithyroid drugs—methimazole, carbimazole, and propylthiouracil Orna Diav-Citrin, Orna Diav-Citrin The Israeli Teratogen Information Service, Israeli Ministry of Health, Jerusalem, IsraelSearch for more papers by this authorAsher Ornoy, Corresponding Author Asher Ornoy [email protected]> The Israeli Teratogen Information Service, Israeli Ministry of Health, Jerusalem, Israel Laboratory of Teratology, the Hebrew University Hadassah Medical School, Jerusalem, IsraelThe Israeli Teratogen Information Service, Laboratory of Teratology, The Hebrew University, Hadassah Medical School, PO Box 12272, Jerusalem, Israel 91120.Search for more papers by this author Orna Diav-Citrin, Orna Diav-Citrin The Israeli Teratogen Information Service, Israeli Ministry of Health, Jerusalem, IsraelSearch for more papers by this authorAsher Ornoy, Corresponding Author Asher Ornoy [email protected]> The Israeli Teratogen Information Service, Israeli Ministry of Health, Jerusalem, Israel Laboratory of Teratology, the Hebrew University Hadassah Medical School, Jerusalem, IsraelThe Israeli Teratogen Information Service, Laboratory of Teratology, The Hebrew University, Hadassah Medical School, PO Box 12272, Jerusalem, Israel 91120.Search for more papers by this author First published: 04 January 2002 https://doi.org/10.1002/tera.1096Citations: 77AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL LITERATURE CITED Albee RR, Mattsson JL, Johnson KA, Kirk HD, Breslin WJ. 1989. Neurological consequences of congenital hypothyroidism in Fischer 344 rats. Neurotoxicol Teratol 11: 171– 183. Bachrach LK, Burrow GN. 1984. Aplasia cutis congenita and methimazole [letter]. Can Med Assoc J 130: 1264. Becks GP, Burrow GN. 1991. Thyroid disease and pregnancy. Med Clin North Am 75: 121– 150. Blunt K, Quan V, Carr D, Paes BA. 1992. Aplasia cutis congenita: a clinical review and associated defects. Neonatal Netw 11: 17– 27. Bruner JP, Dellinger EH. 1997. Antenatal diagnosis and treatment of fetal hypothyroidism. A report of two cases. Fetal Diagn Ther 12: 200– 204. Burrow GN. 1978. Hyperthyroidism during pregnancy. N Engl J Med 298: 150– 153. Burrow GN. 1985. The management of thyrotoxicosis in pregnancy. N Engl J Med 313: 562– 565. Burrow GN. 1993. Thyroid function and hyperfunction during gestation. Endocr Rev 14: 194– 202. Burrow GN, Klatskin EH, Genel M. 1978. Intellectual development in children whose mother received propylthiouracil during pregnancy. Yale J Biol Med 51: 151– 156. Calikoglu AS, Gutierrez-Ospina G, D'Ercole AJ. 1996. Congenital hypothyroidism delays the formation and retards the growth of the mouse primary somatic sensory cortex (S1). Neurosci Lett 213: 132– 136. Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. 1999. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 83: 43– 46. Comer CP, Norton S. 1982. Effects of perinatal methimazole exposure on a developmental test battery for neurobehavioral toxicity in rats. Toxicol Appl Pharmacol 63: 133– 141. Di Gianantonio E, Schaefer C, Mastoiacovo PP, Cournot MP, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M. Adverse effects of prenatal methimazole exposure. Teratology (in press). Dutertre JP, Jonville AP, Moraine C, Autret E. 1991. Aplasia cutis after exposure to carbimazole in utero [French]. J Gynecol Obstet Biol Reprod (Paris) 20: 575– 576. Eisenstein Z, Weiss M, Katz Y, Bank H. 1992. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 151: 558– 559. Farine D, Maidman J, Rubin S, Chao S. 1988. Elevated alpha-fetoprotein in pregnancy complicated by aplasia cutis after exposure to methimazole. Obstet Gynecol 71: 996– 997. Farwell AP, Braverman LE. 1996. Thyroid and antithyroid drugs. In: JG Hardman, LE Limbind, PB Molinoff, RW Ruddon, AG Gilman (eds.) Goodman and Gilman's: The pharmacological basis of therapeutics. 9th Ed. New York: McGraw-Hill. p 1383. Friedland DR, Rothschild MA. 2000. Rapid resolution of fetal goiter associated with maternal Grave's disease: a case report. Int J Pediatr Otolaryngol 54: 59– 62. Ghaneim A, Atkins P. 1998. Management of thyrotoxicosis in pregnancy. Int J Clin Pract 52: 36– 38. Goldey ES, Kehn LS, Rehnberg GL, Crofton KM. 1995. Effects of developmental hypothyroidism on auditory and motor function in the rat. Toxicol Appl Pharmacol 135: 67– 76. Goluboff LG, Sisson JC, Hamburger JI. 1974. Hyperthyroidism associated with pregnancy. Obstet Gynecol 44: 107– 116. Greenberg F. 1987. Choanal atresia and athelia: methimazole teratogenicity or a new syndrome? Am J Med Genet 28: 931– 934. Hall BD. 1997. Methimazole as a teratogenic etiology of choanal atresia/multiple congenital anomaly syndrome [abstract]. Am J Hum Genet 61(Suppl): A100. Hollingsworth PR. 1983. Grave's disease. Clin Obstet Gynecol 26: 615– 634. Holt WA, Talbert LM, Thomas CG Jr, Rankin P. 1970. Hyperthyroidism during pregnancy. Obstet Gynecol 36: 779– 785. Johnsson E, Larsson G, Ljunggren M. 1997. Severe malformations in infant born to hyperthyroid woman on methimazole [letter]. Lancet 350: 1520. Kalb RE, Grossman ME. 1986. The association of aplasia cutis congenita with therapy of maternal thyroid disease. Pediatr Dermatol 3: 327– 330. Kawamura M, Nishimura T, Izumi T, Fukuyama Y. 1989. A case of partial DiGeorge syndrome born to a mother with familial Basedow disease and methimazole treatment during pregnancy. Teratology 40: 663. Koletzko B, Majewski F. 1984. Congenital anomalies in patients with choanal atresia: CHARGE association. Eur J Pediatr 142: 271– 275. Krementz ET, Hooper RG, Larsen PR. 1957. The effect on the rabbit fetus of the maternal administration of propylthiouracil. Surgery 41: 619– 631. Kriplani A, Buckshee K, Bhargava VL, Takkar D, Ammini AC. 1994. Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. Eur J Obstet Gynecol Reprod Biol 54: 159– 163. Lutton D, Fried D, Sibony O, Vuillard E, Tebeka B, Boissinot C, Leger J, Polak M, Oury JF, Blot P. 1997. Assessment of fetal thyroid function by colored Doppler echography. Fetal Diagn Ther 12: 24– 27. Mandel SJ, Brent GA, Larsen PR. 1994. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 4: 129– 133. Marchant B, Brownlie EW, Hart DM, Horton PW, Alexander WD. 1977. The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 45: 1187– 1193. Martin-Denavit T, Edery P, Plauchu H, Attia-Sobol J, Raudrant D, Aurand JM, Thomas L. 2000. Ectodermal abnormalities associated with methimazole intrauterine exposure [letter]. Am J Med Genet 94: 338– 340. Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, Urioste M. 1992. Methimazole in animal feed and congenital aplasia cutis [letter]. Lancet 339: 742– 743. McCarroll AM, Hutchinson M, McAuley R, Montgomery DA. 1976. Long-term assessment of children exposed in utero to carbimazole. Arch Dis Child 51: 532– 536. Messer PM, Hauffa BP, Olbricht T, Benker G, Kotulla P, Reinwein D. 1990. Antithyroid drug treatment of Graves disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 123: 311– 316. Mestman JH, Goodwin TM, Montoro MM. 1995. Thyroid disorders of pregnancy. Endocrinol Metab Clin North Am 24: 41– 71. Milham S Jr, Elledge W. 1972. Maternal methimazole and congenital defects in children [letter]. Teratology 5: 125– 126. Milham S Jr. 1985. Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy [letter]. Teratology 32: 321. Momotani N, Ito K. 1991. Treatment of pregnant patients with Basedow's disease. Exp Clin Endocrinol 97: 268– 274. Momotani N, Ito K, Hamada N, Ban Y, Nishikawa Y, Mimura T. 1984. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 20: 695– 700. Momotani N, Noh JY, Ishikawa N, Ito K. 1997. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Grave's hyperthyroidism. J Clin Endocrinol Metab 82: 3633– 3636. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I. 1997. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 82: 3099– 3102. Mujtaba Q, Burrow GN. 1975. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstet Gynecol 46: 282– 286. Ornoy A, Segal J, Bar-Hamburger R, Greenbaum C. 2001. The developmental outcome of school age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 43: 668– 675. Peterson RR. 1953. Comparison of the effects of placental transmission of propyl- and iodothiouracil in the guinea pig. Anat Rec 115: 359– 360. Porreco RP, Bloch CA. 1990. Fetal blood sampling in the management of intrauterine thyrotoxicosis. Obstet Gynecol 76: 509– 512. Ramirez A, Espinosa de los Monteros A, Parra A, De Leon B. 1992. Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole (Tapazol®) during pregnancy. Am J Med Genet 44: 200– 202. Ramsay I, Kaur S, Krassas G. 1983. Thyrotoxicosis in pregnancy: results of treatment by antithyroid drugs combined with T4. Clin Endocrinol (Oxf) 18: 73– 85. Refetoff S, Ochi Y, Selenkow HA, Rosenfield RL. 1974. Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs. J Pediatr 85: 240– 244. Rice SA, Millan DP, West JA. 1987. The behavioral effects of perinatal methimazole administration in Swiss Webster mice. Fundam Appl Toxicol 8: 531– 540. Sargent KA, Stopfer JE, Mallozzi M, Khandelwal M, Quashie C, Schneider AS. 1994. Apparent scalp-ear-nipple (Findlay) syndrome in a neonate exposed to methimazole in-utero [abstract]. Am J Hum Genet 55(Suppl): A312. Schardein JL. 1993. Chemically induced birth defects. 2nd Ed. New York: Marcel Dekker, Inc. Shikii A, Izumi T, Uehara T, Fukuyama Y. 1989. A case of hydrops fetalis, minor anomalies and symptomatic West syndrome born to a mother with Basedow disease and thiamazole treatment. Teratology 40: 663. Shoenfeld Y, Schwartz RS. 1984. Immunologic and genetic factors in autoimmune diseases. N Engl J Med 311: 1019– 1029. Stanisstreet M, Herbert LC, Pharoah POD. 1990. Effects of thyroid antagonists on rat embryos cultured in vitro. Teratology 41: 721– 729. Sugrue D, Drury MI. 1980. Hyperthyroidism complicating pregnancy: results of treatment by antithyroid drugs in 77 pregnancies. Br J Obstet Gynaecol 87: 970– 975. Tanaka S, Yamashita Y, Koga Y, Hagisawa M, Hanatani K, Fujimoto S. 1989. Three cases of neonatal congenital anomalies associated with maternal hyperthyroidism [abstract]. Teratology 40: 673– 674. Treadwell MC, Sherer DM, Sacks AJ, Ghezzi F, Romero R. 1996. Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism. Obstet Gynecol 87: 838– 840. Van Dijke CP, Heydendael RJ, De Kleine MJ. 1987. Methimazole, carbimazole, and congenital skin defects. Ann Intern Med 106: 60– 61. Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. 1996. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. BMJ 313: 539– 544. Vogt T, Stolz W, Landthaler M. 1995. Aplasia cutis congenita after exposure to methimazole: a causal relationship? Br J Dermatol 133: 994– 996. Wallace C, Couch R, Ginsberg J. 1995. Fetal thyrotoxicosis: a case report and recommendations for prediction, diagnosis, and treatment. Thyroid 5: 125– 128. Wilson LC, Kerr BA, Wilkinson R, Fossard C, Donnai D. 1998. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet 75: 220– 222. Wing DA, Millar KL, Koonings PP, Montoro MN, Mestman JH. 1994. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 170: 90– 95. Zimmerman D. 1999. Fetal and neonatal hyperthyroidism. Thyroid 9: 727– 733. Zolcinski A, Heimrath T, Rzucidlo Z. 1964. Effect of thiamazole (methimazole) on fetal development in rabbits. Gynekol Pol 35: 593– 596. Citing Literature Volume65, Issue1January 2002Pages 38-44 ReferencesRelatedInformation